The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Takayasu Arteritis

Large Vessel Vasculitis Affecting the Aorta and Major Branches

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is Takayasu Arteritis?

Takayasu arteritis is a systemic large vessel vasculitis of unknown etiology affecting primarily the aorta, its main branches, and pulmonary arteries. The disease typically presents in women younger than 40 years, with higher prevalence in Asian populations, particularly from Japan, India, and Turkey.

The pathological process involves granulomatous inflammation of the arterial wall progressing through three stages: early systemic inflammation, vessel inflammation with symptoms, and chronic fibrotic phase with stenosis or aneurysm. The aortic arch and its branches, abdominal aorta, and renal arteries are commonly affected.

Cardiovascular complications include hypertension from renal artery involvement, coronary artery ostial stenosis, aortic regurgitation from aortic root dilation, and heart failure from pressure overload or myocarditis. Cerebral ischemia may result from supra-aortic vessel involvement.

Diagnosis utilizes the 2022 ACR/EULAR classification criteria combined with imaging evidence from CT angiography, MR angiography, or FDG-PET/CT demonstrating characteristic vessel wall thickening, stenosis, occlusion, or aneurysmal changes in affected arteries.

Symptoms

Upper extremity claudication and asymmetric blood pressure between arms
Absent or diminished peripheral pulses with vascular bruits
Constitutional symptoms including fever, weight loss, and malaise
Hypertension particularly in young patients
Chest pain, dyspnea, or symptoms of heart failure
Neurological symptoms including syncope, headache, or visual disturbances

Risk Factors

Female sex with 8-9 times higher incidence than males
Age less than 40 years at disease onset
Asian, Middle Eastern, or Latin American ethnicity
Genetic predisposition with HLA-B*52 association
Family history of autoimmune disease
Environmental factors possibly including mycobacterial antigens

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Young women with asymmetric blood pressure or absent peripheral pulses require rheumatology and vascular medicine evaluation
  • Unexplained constitutional symptoms with elevated inflammatory markers in young patients warrant vasculitis workup
  • Known Takayasu patients developing new symptoms or disease flares require urgent specialist assessment

Treatment Methods

01
High-dose corticosteroid therapy typically prednisone 1 mg/kg/day for induction of remission
02
Steroid-sparing immunosuppressants including methotrexate, azathioprine, or mycophenolate mofetil
03
Biologic agents such as tocilizumab or TNF inhibitors for refractory or relapsing disease
04
Antihypertensive therapy with careful monitoring in patients with renal artery stenosis
05
Endovascular interventions including balloon angioplasty or stenting for critical stenosis
06
Surgical bypass or vessel reconstruction for severe stenotic disease not amenable to endovascular treatment

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.